Declaratory Relief after Medimmune

47 Pages Posted: 6 Dec 2019

Date Written: 2010

Abstract

In MedImmune, Inc. v. Genentech, Inc., the Supreme Court of the United States rejected the Federal Circuit's "reasonable apprehension of imminent suit" test for determining the existence of a justiciable controversy in actions for declaratory relief involving alleged or potential patent infringement. The Supreme Court substituted the totality-of-circumstances test, which has long been used trans-substantively in actions for declaratory relief. Justice Clarence Thomas, the lone dissenter, contended that the majority's holding would allow parties to seek improper advisory opinions. This Article evaluates MedImmune's impact on declaratory judgment actions in patent litigation and considers whether Justice Thomas's prediction was accurate. To do so, this Article compares how the Federal Circuit and other federal courts addressed justiciability in patent cases in the three years before and after the Supreme Court announced its MedImmune decision in January 2007. The Article also examines how lower courts have (and have not) utilized their discretion to decline to hear actions for declaratory relief in Patent litigation. In sum, MedImmune appears to have had the results desired by the Court majority:

(1) Parties can more easily demonstrate the existence of a controversy in order to question arguably coercive measures by patentees in court; and

(2) The lower courts have adhered to a reasonable notion of when a sufficiently concrete controversy exists, even though they have not utilized the discretion to decline actions for declaratory relief as often as they might.

Justice Thomas's concern that MedImmune would unleash a torrent of hypothetical actions in and out of the realm of patent litigation does not appear to be coming to fruition.

Suggested Citation

Levine, David I. and Belle, Charles, Declaratory Relief after Medimmune (2010). Lewis & Clark Law Review, Vol. 14, 2010, UC Hastings Research Paper No. 374, Available at SSRN: https://ssrn.com/abstract=3498601

David I. Levine (Contact Author)

UC Hastings Law ( email )

200 McAllister Street
San Francisco, CA 94102
United States
415-565-4677 (Phone)

Charles Belle

UC Hastings Law ( email )

200 McAllister Street
San Francisco, CA 94102
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
4
Abstract Views
158
PlumX Metrics